LOEST Trademark

Trademark Overview

On Wednesday, November 9, 2016, a trademark application was filed for LOEST with the United States Patent and Trademark Office. The USPTO has given the LOEST trademark a serial number of 87231603. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2020. This trademark is owned by Allergan Pharmaceuticals International Limited. The LOEST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, oral contraceptives and pharmaceuticals for use in hormone replacement therapy
loest

General Information

Serial Number87231603
Word MarkLOEST
Filing DateWednesday, November 9, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, oral contraceptives and pharmaceuticals for use in hormone replacement therapy
Translation of Words in MarkThe English translation of "LOEST" in the mark is "SOLVES".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Pharmaceuticals International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE
Party NameAllergan Pharmaceuticals International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCoolock, Dubin 17
IE

Trademark Events

Event DateEvent Description
Monday, January 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2019EXTENSION 3 GRANTED
Friday, March 15, 2019EXTENSION 3 FILED
Friday, March 15, 2019TEAS EXTENSION RECEIVED
Tuesday, November 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 9, 2018EXTENSION 2 GRANTED
Friday, November 9, 2018EXTENSION 2 FILED
Friday, November 9, 2018TEAS EXTENSION RECEIVED
Tuesday, May 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 18, 2018EXTENSION 1 GRANTED
Friday, May 18, 2018EXTENSION 1 FILED
Friday, May 18, 2018TEAS EXTENSION RECEIVED
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 9, 2017LETTER OF SUSPENSION E-MAILED
Friday, June 9, 2017SUSPENSION LETTER WRITTEN
Thursday, June 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION WRITTEN
Thursday, December 8, 2016ASSIGNED TO EXAMINER
Tuesday, November 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 12, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

loest hormone replacement therapy pharmaceuticals contraceptives preparations namely oral pharmaceutical